Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Cyclavance
Active substances:
Estonian, English, Latin
ATC code: QL04AD01
Dosage form: oral solution
Strength: 100mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated April 4, 2024)
Package information leaflet (PIL): EST  (last updated April 4, 2024)
Labelling:  (last updated April 4, 2024)
Indication: Treatment of chronic manifestations of atopic dermatitis in dogs. Symptomatic treatment of chronic allergic dermatitis in cats.
Safety features: No
Marketing authorization holder: Virbac 
Marketing authorization number: 1823 
Marketing authorization issued on: March 18, 2014 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated March 25, 2014) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1611740  Cyclavance  oral solution  100mg 1ml 5ml 1TK  Prescription           
1611751  Cyclavance  oral solution  100mg 1ml 15ml 1TK  Prescription      05.10.2023     
1611762  Cyclavance  oral solution  100mg 1ml 30ml 1TK  Prescription           
1611773  Cyclavance  oral solution  100mg 1ml 60ml 1TK  Prescription           
1660182  Cyclavance  oral solution  100mg 1ml 50ml 1TK  Prescription      31.07.2023     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere